A visionary company
Transforming ophthalmic care with sustained release therapies
Hydrogel Technology
A platform Engineered for Ocular Innovation
Focused on the future
Developing therapies to enhance the current standard of care
Driven by a vision
Pioneering a new era of drug delivery in ophthalmology
Ocular Therapeutix is a biopharmaceutical platform company leveraging its formulation expertise to develop transformational drug treatments that enhance people’s lives.
Featured Press Release
FDA Accepts DEXTENZA NDA Submission
Action Date: Dec. 28, 2018